Debate: Surgery vs. Brachytherapy for Intermediate and High-Risk Prostate Cancer- Brachytherapy 

Mira Keyes, MD, FRCPC, a Clinical Professor at the University of British Columbia (UBC) and a radiation oncologist at the Vancouver Centre of the British Columbia Cancer Agency (BCCA), presents an informative discussion on the benefits of brachytherapy compared to surgery and external beam radiation for prostate cancer treatment. Dr. Keyes explores how brachytherapy outperforms surgery in terms of PSA (prostate-specific antigen) and metastasis-free survival outcomes in high-risk and unfavorable intermediate-risk patients.